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Abstract Impulsive-compulsive disorders are frequent in
patients with Parkinson’s disease (PD). Recently, a
screening questionnaire and rating scale were developed
for these disorders: the questionnaire for impulsive-com-
pulsive disorders (QUIP) and QUIP-rating scale (QUIP-
RS). We assessed the validity of these instruments in the
German language in order to reevaluate the benefit and to
obtain German screening tools in clinical practice. A
convenience sample of 156 patients was assessed in Kiel
and Vienna. The patients filled out the QUIP-current, the
QUIP-anytime and the QUIP-RS. We validated the ques-
tionnaires against a gold standard diagnosis via receiver
operating characteristic curves and determined optimal cut-
off scores for the instruments. Excluding walkabout, which
was not shown to be valid, sensitivities ranged from
60–92 % for the QUIP-current, 68–91 % for the QUIP-
anytime, and 73–100 % for the QUIP-RS. Specificities
were [71 % for QUIP-current, [69 % for QUIP-anytime
and [62 % for QUIP-RS. With its very good sensitivities,
the QUIP-RS is a valid instrument to assess impulsive-
compulsive disorders and makes an early detection of
behavioral disorders in PD possible. The QUIP-anytime
was also shown to be a valid screening instrument. Both are
expected to prove useful in scientific and clinical practice.
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Introduction
Within the last several years, impulsive-compulsive disorders
have been recognized as side effects of dopamine replace-
ment therapy in Parkinson’s disease (PD) [1]. The largest
epidemiological study found impulse control disorders
(ICDs: pathological gambling, hypersexuality, excessive
buying or binge eating) in 14 % of medicated PD patients and
17 % of PD patients treated with dopamine agonists [2].
Aside from the ICDs, other repetitive, compulsive behaviors
develop as a consequence of dopaminergic medication.
Punding has been defined by repetition of simple motor
actions, e.g. excessive and aimless sorting or manipulation of
items [3]. Hobbyism is a more complex form of punding:
patients are overly engaged with their hobbies and neglect
other activities (e.g. hygiene) [3]. Sometimes, walkabout
(excessive and aimless walking) is described as an indepen-
dent disorder [4]. Furthermore, some patients develop dopa-
mine dysregulation syndrome (DDS) which is characterized
by an addiction-like use of dopaminergic medication [4].
Common features of the disorders are that patients
perform specific behaviors excessively, eventually lose
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control over them and consequently have to face serious
socio-economic consequences [3]. Early interventions, i.e.
medication changes or psychotherapeutic support, effec-
tively improve symptoms and can prevent severe conse-
quences [5]. However, some patients have no insight or do
not associate their behaviors with dopaminergic medica-
tion, and thus do not report them to the neurologist.
Until recently there was no questionnaire for efficient
early detection of these disorders in PD patients [6].
Therefore, Weintraub et al. [7] developed the questionnaire
for impulsive-compulsive disorders in Parkinson’s disease
(QUIP) and the questionnaire for impulsive-compulsive
disorders in Parkinson’s disease-rating scale (QUIP-RS)
[6]. The QUIP screens for pathological gambling, hyper-
sexuality, excessive buying, overeating, punding, hobby-
ism, walkabout and DDS. The QUIP-RS assesses the
severity of the same behaviors (excluding walkabout) with
a Likert scale.
The American validation of the questionnaires has
provided satisfactory sensitivities and specificities [6, 7].
We performed an independent validation of the German
versions of QUIP and QUIP-RS in order to add information
to their clinimetric properties and to have quality criteria
for use in the German language.
Method
Questionnaires
There are two versions, current and anytime, for the QUIP
and a current version for the QUIP-RS. The current ques-
tionnaires assess the symptoms for the last 4 weeks, the
anytime questionnaire asks about the 4 weeks with the
worst symptoms since the beginning of PD. Apart from the
time frame, the two QUIP versions are identical. The
questionnaires validated in the present study are provided
in the supplementary section (including scoring
information).
QUIP
A description of the questionnaire development is found in
[7]. The QUIP was translated into German, retranslated
into English by a native speaker and finally proof-read by
the primary author of the original version (D.W.). The
QUIP is a dichotomous questionnaire which can be filled
out by the patient, with the help of a third person or by a
third person alone.
For scoring, positive answers for each disorder are
summed up leading to a maximum of five points for each of
the ICDs and DDS, and three points for punding, hobbyism
and walkabout.
QUIP-RS
The QUIP-RS [6] was derived from the QUIP with the aim
to create a rating scale that assesses severity and change of
symptoms. Unlike the QUIP, walkabout is not listed as an
independent disorder in the rating scale. The translation
procedure was the same as for the QUIP. Additionally,
eight PD patients and five healthy controls evaluated the
questionnaire concerning readability. Subsequently,
improvements in wording were made. Finally, a native
speaker translated the QUIP-RS back into English and the
primary author (D.W.) confirmed these changes.
The QUIP-RS consists of an instruction sheet and a
second sheet with four questions which have to be
answered for each disorder on a 5-point Likert scale.
Scoring range for each scale (i.e. disorder) is 0–16. The
QUIP-RS can be answered by the patient, with the help of a
third person or by a third person alone.
Diagnostic interview
In order to validate the questionnaires against a gold stan-
dard, we developed a semistructured diagnostic interview
based on the procedure of the American validation [6]. We
included the diagnostic statistical manual of mental disor-
ders IV-TR criteria for binge eating and a structured clinical
interview for pathological gambling [8, 9]. The criteria for
binge eating were adapted to include episodes of general
overeating [7]. For hypersexuality and excessive buying the
currently proposed research criteria were used [3, 10]. The
sections for punding, hobbyism, walkabout and DDS were
based on common descriptions of the symptoms [1, 3, 4].
To exclude manic or hypomanic episodes as differential
diagnoses we also assessed the corresponding symptoms
[11]. Furthermore, we included the Structured Clinical
Interview for DSM-IV Axis I disorders section for
depressive/dysthymic symptoms [11].
The disorders were assessed for several time frames: (1)
the time of the interview and the 4 weeks before filling out
the QUIP-RS, (2) the 4 weeks before filling out the QUIP,
(3) a time frame of at least 4 weeks with the worst
symptoms during PD, (4) a time frame of at least 4 weeks
with the worst symptoms before the beginning of PD.
For each of the disorders a severity index was
determined:
0. Not present.
1. Subsyndromal, i.e. significant change in behavior or
marked distress present but not all of A or B criteria
are fulfilled (e.g. for pathological gambling, only four
instead of five A-criteria are met; or for binge eating,
only general overeating present).
2. Criteria met—weak manifestation.
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3. Criteria met—moderate manifestation.
4. Criteria met—strong manifestation.
The manifestation level was determined by the sub-
jective distress felt by the patient and/or the dimensions of
consequences of the disorder.
Patient sample and validation process
The sample consisted of 156 PD patients (106 male). The
data were collected between October 2011 and July 2013 in
two centers: Kiel (133 patients) and Vienna (23 patients).
The study was approved by the local ethics committees and
conducted according to the Declaration of Helsinki [12].
Kiel sample
We sent a letter with study description, consent form and
German versions of QUIP-current and QUIP-anytime to
1,207 PD patients of the Department of Neurology in Kiel.
Patients were asked to fill out the questionnaires on their own
or with a partner and return those together with the signed
consent form. Mail was returned as undeliverable in 265
cases. Three hundred and eighty-seven patients (response
rate 32.06 %) sent back completed forms. These returns
were classified as symptomatic and non-symptomatic based
on the American norms of the QUIP-current [7]. The final
sample consisted of 65 positively and 65 negatively screened
patients (matched for gender and age). They filled out the
QUIP-RS in the study center and were subsequently inter-
viewed. This selection process guaranteed an adequate
number of positives for validation. Three more patients were
recruited from the ward of the Department of Neurology.
Two psychologists, C.P. and B.M., conducted the
interviews. They agreed upon a standardized application of
the diagnostic criteria together with a psychiatrist (D.W.)
and a neurologist (T.E.). The psychologists evaluated the
first six patients together and were blinded to the outcome
of the questionnaires, which guaranteed an independent
gold standard diagnosis.
Thirteen patients of the Kiel sample filled out the
questionnaires with help from a third person and were,
therefore, interviewed with the respective partner. These
data were included in the sample data and were not ana-
lyzed separately.
With the aim to assess test–retest reliability, 116 patients
filled out the QUIP-RS a second time after a period of
11–18 days.
Vienna sample
There were two minor differences in the validation pro-
cedure. In contrast to the Kiel sample, the 23 Austrian
patients were directly recruited from in- or outpatients of
the Department of Neurology of the Donauspital Wien.
Moreover, patients filled out the questionnaires after the
diagnostic interview.
Analyses
The questionnaire scales were validated against the diag-
noses of the interview. For the QUIP-RS, the diagnoses of
time frame 1 were used and for the QUIP-current, the ones
of time frame 2. For the QUIP-anytime, the time frames 2
and 3 were combined. In order to detect vulnerable patients
as early as possible, subsyndromal cases were included in
the calculation as positives.
Receiver operating characteristic (ROC) curves and area
under the curves (AUC) were calculated for each scale.
The final cut-off scores were defined using the Youden
index [13], if sensitivities exceeded 0.7 and specificities
were C0.6. Otherwise, we tried to find a cut-off with a
sensitivity C0.7 and a specificity C0.6. This procedure was
implemented in order to detect as many patients as possible
but at the same time keeping the test efficient and mean-
ingful by trying to keep false-positives low.
The retest reliabilities of the QUIP-RS were determined
via ICC (2, 1) [14].
To explore if data quality differed between the two
centers, ROC curves were calculated separately for Kiel
and Vienna and were compared with Venkatraman’s test
for two unpaired ROC curves [15].
In clinical practice, it may be useful to make the patient
and the informant complete the questionnaires separately
[16]. However, a separate analysis of the subgroup that
filled out the questionnaires with the help of a partner could
not be done in the present study due to the low number of
these cases (n = 13).
Subjects with missing values were deleted in the cal-
culation in a pairwise manner. SPSS Statistics 21.0 Soft-
ware (IBM SPSS Inc. Chicago, IL) and GNU R statistics
were used for the analysis.
Results
Sample characteristics
A sample description regarding age, PD duration, medi-
cation use, brain stimulation and depression can be found
in Table 1. Six patients reported manic or hypomanic
symptoms in one of the time frames but these symptoms
did not coincide with any impulsive-compulsive disorder.
At the time of the interview, 33 patients were diagnosed
with at least one impulsive-compulsive disorder. Including
the subsyndromal cases, 72 patients were classified as
938 J Neurol (2014) 261:936–942
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symptomatic via the diagnostic interview. Figure 1 dis-
plays the relative frequencies of the individual disorders.
Twenty-five patients with at least subsyndromal symptoms
had more than one diagnosis at the time of the interview.
Note: our patient sample was preselected. Therefore, the
frequencies of the disorders are not representative.
Over the course of PD, 52 patients had at least one
behavioral disorder (82 including subsyndromal cases).
The diagnoses (including subsyndromal cases) are as fol-
lows: pathological gambling, 9.0 % (9.0 %); hypersexual-
ity, 14.7 % (23.7 %); excessive buying, 9.0 % (12.8 %);
binge eating, 10.9 % (20.5 %); punding, 6.4 % (11.5 %);
hobbyism, 10.3 % (17.3 %); walkabout, 3.2 % (4.5 %);
and DDS, 8.3 % (9.0 %).
QUIP-current
One hundred and fifty-six patients filled out the QUIP-
current. AUC, the optimal cut-off scores, corresponding
sensitivities and specificities are seen in Table 2. Four
scales showed sensitivities below 0.7, but all specificities
were C0.71. Still, the scales for walkabout and DDS did
not reach a significant AUC at all.
There were no significant differences between the ROC-
curves of the Kiel and Vienna samples (p values between
0.33 and 0.99).
QUIP-anytime
The QUIP-anytime was completed by 150 subjects.
Table 3 shows the optimal cut-offs and corresponding
sensitivities, specificities and AUC. The punding and
walkabout scales had sensitivity values \0.7, but the
remaining scales reached sensitivities C0.76 and all scales
showed specificities C0.7. The AUC of the walkabout scale
was not significantly different from 0.5.
The separately calculated ROC curves for the two cen-
ters did not differ significantly for any of the scales
(p values between 0.14 and 0.72).
QUIP-RS
Validity
One hundred and fifty-four patients filled out the QUIP-RS.
In Table 4 the optimal cut-off scores as well as
Table 1 Description of the patient groups with (positives) and without (negatives) at least subsyndromal disorders at the time of the interview

















At the time of the interview
Whole sample (n = 156) 63.12 (9.87) 9.46 (6.15) 869.95 (663.05) 166.43 (155.93) m = 105
f = 51
26 35
Positives (n = 72) 61.94 (9.94) 9.08 (5.36) 980.00 (761.67) 167.91 (152.30) m = 50
f = 22
10 26
























Since the beginning of PD
Positives (n = 82) 61.51 (10.02) 9.51 (5.62) 958.73 (727.58) 163.31 (154.54) m = 59
f = 23
13 42











p = 0.04 (one-
sided)











One-sided p values are used, if a hypothesis based on the current state of research was possible (ICD patients are younger, take higher medication
dosages and have a higher prevalence of depression [2]). One-sided p values B0.05 and two-sided p values B0.1 were defined as signifi-
cant (written in bold)
M mean, SD standard deviation, LEDD Levodopa daily equivalence dose, LEDDA dopamine agonist equivalence dose (calculated as in [17]),
DBS deep brain stimulation
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corresponding sensitivities, specificities and AUC are lis-
ted. All sensitivities reached values C0.73; only two
specificities fell below 0.70.
In contrast to the American validation, the validity of the
punding and hobbyism scales did not improve by merging
these scales (an AUC of 0.75 vs. 0.79 and 0.76). Therefore,
we kept them as two separate scales. For hypersexuality
and punding, the cut-off was determined in deviation from
the Youden index. Figure 2 shows the ROC curves for the
ICDs scales.
Means and standard deviations of the QUIP-RS scores can
be found in the supplementary table (Supplementary 4).
Again, the comparison between the Vienna and Kiel
ROC curves did not reveal any significant differences
(p values between 0.23 and 1).
Test–retest reliability
Twenty-seven questionnaires showed missing values in at
least one scale. The ICC reliabilities were as follows:
pathological gambling, r = 0.73; sex, r = 0.80; excessive
buying, r = 0.71; binge-eating, r = 0.78; punding,
r = 0.64; hobbyism, r = 0.57; DDS, r = 0.61; and for the
entire QUIP-RS (sum score), r = 0.78.
Discussion
The aim of the present study was to validate indepen-
dently the QUIP-current, QUIP-anytime and the QUIP-RS
and to obtain quality criteria for the German versions. In
Table 2 AUC as well as sensitivities and specificities for the chosen
cut-off scores for the QUIP-current scales
n AUC Cut-off Sensitivity Specificity
Gambling 153 0.84** 1 0.71 0.93
Sex 152 0.73*** 1 0.67 0.80
Buying 153 0.92*** 1 0.92 0.87
Eating 152 0.83*** 1 0.76 0.84
Punding 154 0.75** 1 0.71 0.81
Hobbyism 151 0.71** 1 0.67 0.71
Walkabout 155 0.65 1 0.40 0.90
DDS 155 0.74 1 0.60 0.84
n subjects without missing values for the respective scale, italics
sensitivities and specificities \0.70
** p \ 0.01, *** p \ 0.001
Table 3 AUC as well as sensitivities and specificities for the chosen
cut-off scores for the QUIP-anytime scales
n AUC Cut-off Sensitivity Specificity
Gambling 141 0.91*** 3 0.83 0.98
Sex 142 0.79*** 1 0.75 0.79
Buying 139 0.90*** 1 0.86 0.90
Eating 139 0.85*** 1 0.78 0.88
Punding 149 0.75*** 1 0.69 0.81
Hobbyism 148 0.76*** 1 0.78 0.70
Walkabout 148 0.59 1 0.25 0.92
DDS 148 0.92*** 1 0.91 0.86
n subjects without missing values for the respective scale, italics
sensitivities and specificities \0.70
** p \ 0.01, *** p \ 0.001
Fig. 1 Relative frequencies of
the impulsive-compulsive
disorders at the time of the
interview
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German speaking countries it is now possible to detect
impulsive-compulsive disorders at an early stage and
initiate interventions to prevent further consequences. The
questionnaires also constitute necessary tools for scientific
use.
Sensitivities and specificities of the QUIP-current
proved to be satisfactory for pathological gambling, buy-
ing, eating and punding. Moderate sensitivities from 0.60
to 0.67 were found for the scales sex, hobbyism and DDS.
The QUIP-anytime showed very good sensitivities and
specificities (from 0.70 to 0.98) for the ICDs and DDS.
With a value of 0.69, the sensitivity for punding was
slightly lower. Walkabout has not turned out to be a valid
scale for the QUIP questionnaires.
For the QUIP-RS, we found cut-offs with very good
sensitivities (between 0.73 and 1) for all of the scales.
Specificities for hobbyism and punding were moderate with
values of 0.62 and 0.65. Compared to low sensitivities (i.e.
a high false-negative rate), low specificities (i.e. a high
false-positive rate) can be tolerated in a screening instru-
ment, since false-positive patients may be at increased risk
of developing a disorder in the future. The retest-reliabil-
ities of the QUIP-RS can be considered satisfactory for the
ICD scales and the entire questionnaire (r ranging from
0.71 to 0.80). For the remaining scales we only found
moderate reliabilities (r between 0.57 and 0.64).
In the long run, the QUIP-RS will probably prove more
useful than the QUIP-current because of better sensitivity,
good retest reliability, and the possibility to assess symp-
tom severity. Especially with regard to the detection of
DDS, the QUIP-RS appears to be the better instrument
since the AUC for this disorder is not significant in the
QUIP. Albeit, we have to acknowledge that the low num-
ber of diagnoses (6) for this disorder makes the data vul-
nerable to biases in all three of the questionnaires. In any
case, in clinical practice, a more detailed examination
should be done to confirm the preliminary classification of
the questionnaires.
The sensitivities and specificities found in the present
study are not as good as the ones found by Weintraub et al.
[7] for QUIP and QUIP-RS [6]. This might be due to lin-
guistic differences occurring after the translation or a
diverging distribution of the diagnoses. Also, differences in
the validation procedure may have led to differing results.
Our sample was mostly recruited via mail, whereas in the
American validation, the patients were included in the
context of routine clinical care. Furthermore, in the present
study the QUIP-current was completed at home, in the US,
on the contrary, it was filled out in the study center.
Our findings show that the ICD scales generally have
good validity values, whereas the remaining scales are
limited in their validity. Walkabout could not be assessed
with the QUIP at all. Also, in the American validation of
the QUIP, walkabout and punding showed lower sensitiv-
ities than the other scales. Low or moderate values for
these scales might stem from the lack of commonly
accepted criteria for these disorders and from the fact that
patients do not always have insight into their behaviors
[18]. These conditions may lead to a less valid and more
error-prone assessment. Future research should focus on a
more detailed symptom description and better defined
diagnostic criteria for these disorders.
A limitation of the present study is that we did not
systematically screen for cognitive deficits. However, all
participants were able to follow the instructions and answer
the questions adequately. Therefore, we can assume that
demented patients were implicitly excluded from the study.
Fig. 2 ROC curves of the impulse control disorder scales of the
QUIP-RS
Table 4 AUC as well as sensitivities and specificities for the chosen
cut-off scores for the QUIP-RS scales
n AUC Cut-off Sensitivity Specificity
Gambling 153 0.89*** 3 0.83 0.92
Sex 152 0.82*** 5a 0.73 0.76
Buying 153 0.91*** 5 0.83 0.88
Eating 147 0.89*** 4 0.90 0.72
Punding 151 0.79*** 3a 0.79 0.65
Hobbyism 149 0.76*** 4 0.94 0.62
DDS 153 0.86** 3 1 0.70
n subjects without missing values for the respective scale, italics
sensitivities and specificities \0.70
** p \ 0.01, *** p \ 0.001
a Not determined via Youden index
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For this patient group, the questionnaires do not constitute
suitable screening instruments.
Future studies will need to investigate the sensitivity of
the QUIP-RS to symptom changes after therapeutic inter-
ventions. With validations of the QUIP questionnaires in
further languages and other patient samples taking dopa-
mine agonist therapy, standardized screening and research
tools will be available for use in international multicenter
studies.
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